BioTuesdays

Category - Markets

DBV Technologies
Markets

Stifel cuts DBV Technologies to hold; PT $11

Stifel downgraded DBV Technologies (NASDAQ:DBVT) to “hold” from “buy” and slashed its price target to $11 from $35 after the company withdrew the BLA for its Viaskin peanut allergy treatment after a meeting with the FDA...

December 20, 2018
Brainstorm Cell Therapeutics Logo
Markets

Dawson James starts Brainstorm at buy; PT $12

Dawson James initiated coverage of Brainstorm (NASDAQ:BCLI) with a “buy” rating and $12 price target. The stock closed at $3.05 on Dec. 17. Brainstorm uses autologous cell therapy to treat amyotrophic lateral sclerosis...

December 18, 2018
GlycoMimetics
Markets

HCW starts GlycoMimetics at buy; PT $24

H.C. Wainwright launched coverage of GlycoMimetics (NASDAQ:GLYC) with a “buy” rating and $24 price target based on a positive outlook for the company’s pipeline. The stock closed at $10.29 on Dec. 17...

December 18, 2018
Novavax Logo
Markets

Ladenburg starts Novavax at buy; PT $3

Ladenburg Thalmann initiated coverage of Novavax (NASDAQ:NVAX) with a “buy” rating and $3 price target, as “we look for transformational data in the first quarter of 2019.” The stock closed at $2.27 on Dec. 17. Novavax...

December 18, 2018
Advaxis Logo
Markets

HCW cuts Advaxis to neutral and removes PT

H.C. Wainwright downgraded Advaxis (NASDAQ:ADXS) to “neutral” from “buy” and removed its price target after Amgen terminated a development and collaboration agreement on ADXS-NEO, Advaxis’ personalized neoantigen...

December 18, 2018
CollPlant
Markets

Roth starts CollPlant at buy; PT $7

Roth Capital Markets launched coverage of CollPlant Holdings (NASDAQ:CLGN) with a “buy” rating and 12-month price target of $7. The stock closed at $4.36 on Dec. 17. CollPlant is the world’s first and only commercial...

December 18, 2018
Arch Therapeutics
Markets

Roth ups Arch Therapeutics PT to $3 from $2.10

Roth Capital Partners raised its price target for Arch Therapeutics (OTCQB:ARTH) to $3 from $2.10 after the FDA cleared the company’s AC5 Topical Gel for use in partial and full-thickness skin wounds, such as pressure...

December 18, 2018